Tune Therapeutics
Ilse Norell Diego has worked in the field of research since 2016. Ilse Norell began their career as a Graduate Research Assistant at the National Natural Toxin Research Center. In 2018, they moved to Catalent Pharma Solutions and held the roles of Sr. Associate Scientist and Associate Scientist. In 2020, they joined StrideBio, Inc. as a Senior Research Associate and is currently in this role at Tune Therapeutics since 2022.
Ilse Norell Diego received their Bachelor of Biomedical Sciences from Texas A&M University-Kingsville in 2015. Ilse Norell then went on to receive their Master of Science in Chemistry from the same university in 2018.
Tune Therapeutics
1 followers
With its versatile and powerful TEMPO epigenomic control platform, Tune Therapeutics is pioneering a new therapeutic modality that can fine-tune any gene network and unlock the full power and potential of regenerative medicine. With deep experience and a passionate commitment to exploration and innovation, Tune is driving through an inflection point in the history of genetic medicine: from targeting a limited range of rare conditions, to addressing thousands of common and complex diseases for which no curative treatment is available.